Thermo Fisher Scientific at US HUPO 2025
Lunchtime seminars
Monday lunchtime seminar | Monday, February 24, 2025 | 12:30 - 1:30 p.m. EST
Breakthroughs in proteomics: Unparalleled sensitivity and coverage
12:30 - 1:30 p.m. EST: Loews Philadelphia Hotel - Room: Commonwealth AB
To push the boundaries of modern proteomics, mass spectrometry must attain unprecedented sensitivity, accuracy, precision, and depth of coverage. Our goal is for mass spectrometers to explore biological systems with exceptional detail and specificity. Through collaboration with leading experts, we have developed innovative instruments and workflows to advance the field. Register now to learn how the scientific community is addressing these challenges in areas like immunopeptidomics and spatial proteomics.
Talk 1: Optimized HLA class I and class II immunopeptidomics on the Orbitrap Astral mass spectrometer
- Speaker: Nicholas Cheung (Sr. Associate Scientist, Regeneron)
Talk 2: High-resolution spatial proteomics using Syncell's microscoop and the Orbitrap Astral mass spectrometer
- Speaker: Azad Gucwa (Sr. Field Application Scientist, Syncell)
Tuesday lunchtime seminar | Tuesday, February 25, 2025 | 12:30 - 1:30 p.m. EST
Innovating for impact: The future of translational research
12:30 - 1:30 p.m. EST: Loews Philadelphia Hotel - Room: Commonwealth AB
In the rapidly evolving field of translational disease research, the journey from biomarker discovery to clinical application is filled with challenges. Biomarker verification is a critical step that can determine the success of your research and its impact on patient outcomes. However, with the right tools and technologies, these obstacles can be transformed into opportunities for groundbreaking advancements. Register now to discover how leading experts in academia and industry are overcoming these challenges as they seek to turn potential biomarkers into actionable insights.
Talk 1: Advancing drug development: Insights into human disease with new proteomics tools
- Speaker: Ray Chen (Senior Director, Olink, Part of Thermo Fisher Scientific)
Talk 2: Quantitative proteomics on a nominal mass instrument to identify signatures of clinically related nephropathies
- Speaker: Dr. Luca Fornelli (Assistant Professor, University of Oklahoma)
Talk 3: New advances in translational proteomics
- Speaker: Bruce Wilcox (CTO, PrognomiQ)
Posters
Monday, February 24, 2025 | 1:30 – 3:00 p.m. EST
Revolutionizing translational research: large-scale targeted PRM proteomics assays enabled by Stellar mass spectrometer
- Qingling Li
Comprehensive plasma proteome profiling with Orbitrap Astral and pre-omics sample preparation kits for high-throughput biomarker discovery
- Jared Deyarmin
High-throughput LC-MS workflows for translational research of a mini cancer cohort using an Orbitrap Astral mass spectrometer
- Kevin Yang
Unveiling hidden depths: a high-throughput plasma proteomics workflow for enhanced biomarker discovery
- Kevin Yang
LC-MS workflows for diverse omics analysis of plasma samples in a mini cancer cohort using the Orbitrap Astral mass spectrometer
- Rahul Deshpande
High-throughput workflow for targeted protein degradation compound screening on an Orbitrap Astral mass spectrometer with accurate quantitation
- Kevin Yang
Enhancing immunopeptide profiling with Orbitrap Astral mass spectrometer for unbiased discovery of neoantigens
- Fernanda Salvato
Label-free DIA-based workflow for single-cell proteomic analysis on an Orbitrap Ascend Tribrid mass spectrometer
- Fernanda Salvato
A semi-targeted Orbitrap Tribrid method for simultaneous quantification and discovery of immunopeptides
- Tonya Hart
COOKIE-Pro: covalent inhibitor binding kinetics profiling on the proteome scale
- Kevin Yang
High-throughput data-independent acquisition mass spectrometry workflow for in-depth identification of protein ubiquitination using an Orbitrap Astral mass spectrometer
- Kevin Yang
Optimized XL-MS workflows for protein-protein and protein-nucleic acid interactions
- Yi He
Simultaneous quantitation and discovery (SQUAD) metabolomics workflow on the Orbitrap IQ-X for the analysis of fecal bile acids
- Bashar Amer
State-of-the-art glycopeptide identification using an Orbitrap Astral mass spectrometer
- Julian Saba
Comprehensive multiomics integration: bridging proteomics and genomics
- Khatereh Motamedchabo
Mass spectrometry-based proteomic investigation of patient-derived tumoroids using the Orbitrap Astral mass spectrometer informs precision oncology and drug discovery
- Dominique Figueroa
Characterizing 32-plex TMTpro reagents for high-throughput quantitative proteomics on Orbitrap platforms
- Dustin Frost
Streamlined automated proteomics sample preparation with novel magnetic beads
- Amarjeet Flora
Advancements in large-scale intact glycopeptide analysis: identification of novel glycopeptides and performance evaluation of Orbitrap mass spectrometer
- Amanda Lee
Ultra-sensitive quantitation and rapid method development for targeted immunopeptidomics using the Stellar mass spectrometer
- Ellen Casavant
A novel tandem LC workflow for maximizing mass spectrometer utilization
- Lec Valenta
Maximizing low sample load coverage with 100 nL/min elution using 50cm long mesoporous pillar array columns
- Cristina Jacob
Enhancing protein quantification and sample throughput with the new TMTpro 32plex on Orbitrap Ascend Multiomics Tribrid mass spectrometer
- Rafa Melani
